SGEN   $228.89  0.00% Market Closed

Seattle Genetics Inc
Total Cash 1.24B
totalCashPerShare 6.557
EBITDA -677.36M
Total Debt 124.58M
quickRatio 1.957
currentRatio 2.673
Total Revenue 2.30B
debtToEquity 4.885
Revenue/Share 12.29
ROA -0.12935
ROE -0.2793
grossProfits 207.99M
freeCashflow -277.09M
operatingCashflow -540.15M
earningsGrowth
revenueGrowth 0.271
grossMargins 0.07459
ebitdaMargins -0.29446
operatingMargins -0.35202
profitMargins -0.32614
enterpriseValue 42.04B
forwardPE -156.67123
floatShares 129.83M
sharesOutstanding 188.66M
sharesShort 9.58M
sharesShortPriorMonth 10.42M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.89%
Short Ratio help_outline 8.69%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 13.521
Price To Book help_outline 16.92
earningsQuarterlyGrowth
netIncomeToCommon -750.23M
trailingEps -4.00%
forwardEps -1.46%
enterpriseToEbitda -62.07
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.0 4Q 2023
institutionsCount 891
lastUpdated Feb. 15, 2024, 1:13 p.m.